4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001062993-25-004810
Chief Scientific Officer sold 96,656 shares at an average $6.99 ($675,219)
- Chief Scientific Officer acquired 355,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
ROBINS HARLAN S · Chief Scientific Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-03-04 | Grant or award : show line 1 in the form | +355,000 | 1,376,180 | D | ||
| 2025-03-05 | Sale : show line 2 in the form | −40,603 | $6.98 | $283,409 | 1,335,577 | D |
| 2025-03-05 | Sale : show line 3 in the form | −56,053 | $6.99 | $391,810 | 1,279,524 | D |
| Open-market sales · 96,656 sh · avg $6.99 · $675,219 | ||||||
Loading xslF345X05/form4.xml…